Literature DB >> 24556915

The β-galactosidase (BgaC) of the zoonotic pathogen Streptococcus suis is a surface protein without the involvement of bacterial virulence.

Dan Hu1, Fengyu Zhang1, Huimin Zhang2, Lina Hao3, Xiufang Gong3, Meiling Geng3, Min Cao3, Feng Zheng3, Jin Zhu3, Xiuzhen Pan3, Jiaqi Tang3, Youjun Feng4, Changjun Wang3.   

Abstract

Streptococcal pathogens have evolved to express exoglycosidases, one of which is BgaC β-galactosidase, to deglycosidate host surface glycolconjucates with exposure of the polysaccharide receptor for bacterial adherence. The paradigm BgaC protein is the bgaC product of Streptococcus, a bacterial surface-exposed β-galactosidase. Here we report the functional definition of the BgaC homologue from an epidemic Chinese strain 05ZYH33 of the zoonotic pathogen Streptococcus suis. Bioinformatics analyses revealed that S. suis BgaC shared the conserved active sites (W240, W243 and Y454). The recombinant BgaC protein of S. suis was purified to homogeneity. Enzymatic assays confirmed its activity of β-galactosidase. Also, the hydrolysis activity was found to be region-specific and sugar-specific for the Gal β-1,3-GlcNAc moiety of oligosaccharides. Flow cytometry analyses combined with immune electron microscopy demonstrated that S. suis BgaC is an atypical surface-anchored protein in that it lacks the "LPXTG" motif for typical surface proteins. Integrative evidence from cell lines and mice-based experiments showed that an inactivation of bgaC does not significantly impair the ability of neither adherence nor anti-phagocytosis, and consequently failed to attenuate bacterial virulence, which is somewhat similar to the scenario seen with S. pneumoniae. Therefore we concluded that S. suis BgaC is an atypical surface-exposed protein without the involvement of bacterial virulence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556915      PMCID: PMC3931136          DOI: 10.1038/srep04140

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin.

Authors:  A G Allen; S Bolitho; H Lindsay; S Khan; C Bryant; P Norton; P Ward; J Leigh; J Morgan; H Riches; S Eastty; D Maskell
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Structural insights into the substrate specificity of Streptococcus pneumoniae β(1,3)-galactosidase BgaC.

Authors:  Wang Cheng; Lei Wang; Yong-Liang Jiang; Xiao-Hui Bai; Jun Chu; Qiong Li; Ge Yu; Qiu-Ling Liang; Cong-Zhao Zhou; Yuxing Chen
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

3.  Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors.

Authors:  D Takamatsu; M Osaki; T Sekizaki
Journal:  Plasmid       Date:  2001-03       Impact factor: 3.466

4.  Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs.

Authors:  Yuanyi Li; Gabriela Martinez; Marcelo Gottschalk; Sonia Lacouture; Philip Willson; J Daniel Dubreuil; Mario Jacques; Josee Harel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Role of glucose and CcpA in capsule expression and virulence of Streptococcus suis.

Authors:  J Willenborg; M Fulde; A de Greeff; M Rohde; H E Smith; P Valentin-Weigand; R Goethe
Journal:  Microbiology       Date:  2011-02-24       Impact factor: 2.777

6.  Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.

Authors:  Shichun Lun; Jose Perez-Casal; Wayne Connor; P J Willson
Journal:  Microb Pathog       Date:  2003-01       Impact factor: 3.738

7.  Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France.

Authors:  F Berthelot-Hérault; H Morvan; A M Kéribin; M Gottschalk; M Kobisch
Journal:  Vet Res       Date:  2000 Sep-Oct       Impact factor: 3.683

8.  Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.

Authors:  H E Smith; M Damman; J van der Velde; F Wagenaar; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Human Streptococcus suis outbreak, Sichuan, China.

Authors:  Hongjie Yu; Huaiqi Jing; Zhihai Chen; Han Zheng; Xiaoping Zhu; Hua Wang; Shiwen Wang; Lunguang Liu; Rongqiang Zu; Longze Luo; Nijuan Xiang; Honglu Liu; Xuecheng Liu; Yuelong Shu; Shui Shan Lee; Shuk Kwan Chuang; Yu Wang; Jianguo Xu; Weizhong Yang
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

10.  Use of flow cytometry for the adhesion analysis of Streptococcus pyogenes mutant strains to epithelial cells: investigation of the possible role of surface pullulanase and cysteine protease, and the transcriptional regulator Rgg.

Authors:  Jukka Hytönen; Sauli Haataja; Jukka Finne
Journal:  BMC Microbiol       Date:  2006-02-24       Impact factor: 3.605

View more
  6 in total

1.  The Two-Component Signaling System VraSRss Is Critical for Multidrug Resistance and Full Virulence in Streptococcus suis Serotype 2.

Authors:  Xiaojun Zhong; Yue Zhang; Yinchu Zhu; Wenyang Dong; Jiale Ma; Zihao Pan; Shipra Roy; Chengping Lu; Huochun Yao
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

2.  Isolation and characterization of a native avirulent strain of Streptococcus suis serotype 2: a perspective for vaccine development.

Authors:  Xinyue Yao; Ming Li; Jing Wang; Changjun Wang; Dan Hu; Feng Zheng; Xiuzhen Pan; Yinling Tan; Yan Zhao; Liwen Hu; Jiaqi Tang; Fuquan Hu
Journal:  Sci Rep       Date:  2015-04-20       Impact factor: 4.379

3.  Biochemical and Structural Insights into a Novel Thermostable β-1,3-Galactosidase from Marinomonas sp. BSi20414.

Authors:  Haitao Ding; Qian Zeng; Lili Zhou; Yong Yu; Bo Chen
Journal:  Mar Drugs       Date:  2017-01-08       Impact factor: 5.118

4.  sRNA23, a novel small RNA, regulates to the pathogenesis of Streptococcus suis serotype 2.

Authors:  Quanming Xu; Hong Chen; Wen Sun; Yongyi Zhang; Dewen Zhu; Kul Raj Rai; Ji-Long Chen; Ye Chen
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Two novel regulators of N-acetyl-galactosamine utilization pathway and distinct roles in bacterial infections.

Authors:  Huimin Zhang; Dmitry A Ravcheev; Dan Hu; Fengyu Zhang; Xiufang Gong; Lina Hao; Min Cao; Dmitry A Rodionov; Changjun Wang; Youjun Feng
Journal:  Microbiologyopen       Date:  2015-11-05       Impact factor: 3.139

6.  Inactivation of the htpsA gene affects capsule development and pathogenicity of Streptococcus suis.

Authors:  Hua Ni; Min Li; Qiaoqiao Wang; Jing Wang; Xumiao Liu; Feng Zheng; Dan Hu; Xu Yu; Yifang Han; Qi Zhang; Tingting Zhou; Yiwen Wang; Chunhui Wang; Jimin Gao; Zhu-Qing Shao; Xiuzhen Pan
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.